Abstract
INTRODUCTION
Our key objective was to present a comprehensive discussion of where the
state-of-the-art is in epigenomics technologies and the current and future
commercial potential for the key market segments.
SCOPE OF STUDY
This report contains:
The major epigenomics technologies and developments that are likely to become
commercialized within the next five years Provides detailed market information
for the global epigenomics market including historical data, current
information, and projections to 2012 Offers a focus on particular applications
of epigenomics, including research tools, diagnostics, drugs, and
cloning/tissue engineering Discusses the market in terms of important medical
applications such as biomarkers, cancer therapy, and reproductive technology
Offers a detailed review of important patents and technologies Profiles the
most competitive businesses in the industry.
METHODOLOGY
Based on our analysis, we analyze the potential applications of epigenomics in
each of the major market segments, and forecast sales revenues for 2007
through 2012.
For research tools, the study presents a forecast from 2007 through 2012 for
each of the important products and technologies. For cancer diagnostics, the
report forecasts from 2007 through 2012 the demand for epigenetic-based test
kits by cancer and disease type. Finally, this study forecasts from 2007
through 2012 the market for epigenetic drugs by cancer type.
View Cart
